US$ 27.38
oral glp-1 receptor agonists are generating a great deal of excitement as a potential inflection point in diabetes and obesity care. Amid the enthusiasm, however, a quieter and clinically important issue is Oral GLP-1 Pills for Weight
Description
In the March issue, he wrote about the remarkable life and career of Nobel Laureate Rosalyn Yalow, PhD , the first woman president of the Endocrine Society.

Phase 3 trial results have been recently published for the first pills and they are quite promising

Background Inflammatory bowel disease (IBD) is an idiopathic condition characterized by chronic relapsing inflammation in the gastrointestinal tract

The Week Escape your echo chamber